Acupoint Application With Yanqing Zhitong Ointment for Chronic Non-specific Low Back Pain

Last updated: May 18, 2025
Sponsor: ZhanYJ
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Chronic Pain

Treatment

Acupuncture

Yanqing Zhitong Ointment Acupoint application

Clinical Study ID

NCT06102291
YD202218
  • Ages 18-65
  • All Genders

Study Summary

This is a non-inferiority randomized controlled trial, recruiting 150 patients with chronic non-specific low back pain. The patients will be randomly assigned either to Yanqing Zhitong Ointment acupoint application group (Treatment Group) or the acupuncture group (Control Group) in a 1:1 ratio.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Diagnosed with non-specific low back pain

  2. Aage from 18 to 65

  3. VAS between 4 and 7

  4. No other treatment in the past 3 months

  5. No other simultaneous relevant treatment

  6. Voluntarily joining this study with informed consents

Exclusion

Exclusion Criteria:

  1. Pregnant women

  2. With skin ulcers or contusion wounds

  3. Past history of severe allergy to transdermal preparations

  4. Complicated with serious diseases

Study Design

Total Participants: 150
Treatment Group(s): 2
Primary Treatment: Acupuncture
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
June 30, 2026

Study Description

This is a non-inferiority randomized controlled trial, 150 patients with chronic non-specific low back pain were randomly assigned to acupoint application group and acupuncture group in a 1:1 ratio. The main acupoints are Ashi points, Shenshu(BL23), Guanyuanshu(BL26). The primary outcome measure is the change of McGill Pain Questionnaire (MPQ) before and after treatment.

Connect with a study center

  • Longhua Hospital, Shanghai University of Traditional Chinese Medicine

    Shanghai, 200032
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.